Eliminating Race-Based Diagnostic Equations Closes Critical Gap in Black Kidney Transplant Access

For decades, clinical algorithms used to assess kidney function relied on race-based adjustments that systematically overestimated the health of Black patients' kidneys. This practice routinely delayed vital referrals, keeping thousands of Black Americans with advanced kidney disease off the organ transplant waitlist. A new study highlights how abandoning these race-based equations has begun to dismantle long-standing disparities in kidney care access.

The research, led by investigators at the University of Colorado Anschutz Medical Campus, evaluated the real-world impact of the 2021 race-neutral diagnostic guidelines. By examining national clinical data, researchers found a significant uptick in Black patients who qualified for transplant evaluation and waitlist placement after medical systems stopped using race as an adjusting factor in kidney function tests.

A Legacy of Bias in Diagnostic Algorithms

Traditionally, kidney health has been calculated using estimated Glomerular Filtration Rate (eGFR) equations. For years, these formulas applied a multiplier to Black patients based on the discredited assumption that Black individuals naturally possess higher muscle mass or baseline creatinine levels. In practice, this artificial boost made Black patients' kidneys appear healthier on paper than they actually were.

As a result, many Black patients were denied timely nephrology care, medical interventions, and placement on the kidney transplant waitlist until their illness reached severe, irreversible stages. Because Black Americans face a disproportionately high burden of end-stage renal disease—driven by structural inequities, higher rates of hypertension, and limited healthcare access—the biased diagnostic tool compounded an already critical public health crisis.

Restoring Equity to the Waitlist

In response to advocacy from clinicians, medical students, and health equity researchers, the National Kidney Foundation and the American Society of Nephrology recommended phasing out race-based eGFR calculations in 2021. The new research from CU Anschutz demonstrates that removing race from these clinical calculations has provided an immediate corrective effect, allowing Black patients to gain credit for time lived with advanced kidney disease and securing earlier access to lifesaving transplants.

While the policy shift marks a pivotal step forward, researchers emphasize that changing an equation is only part of the solution. Long-term progress requires expanding the workforce of culturally competent nephrologists and healthcare professionals who can identify kidney disease early and advocate for marginalized patients long before complete organ failure occurs.

The Role of Black Medical Leadership

Addressing deep-seated inequities in kidney care underscores the urgent need for greater representation in medicine. Historically Black Colleges and Universities (HBCUs) train a substantial percentage of Black physicians in the United States, producing leaders uniquely equipped to challenge biased medical models and advance health equity.

By championing race-neutral diagnostics and mentoring the next generation of Black medical researchers, HBCU-trained providers remain at the forefront of reforming medical protocols. Ensuring that clinical algorithms accurately reflect human biology—rather than social constructs—is essential to building a just healthcare system where Black patients receive timely, equity-focused care.